Gtmetabolic
Saint Michael, US · Founded 2020 · 2 known investors
GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.
Founders & leadership
TT
Thierry ThaureinChief Executive Officer
MG
Michel GagnerNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$46.5M disclosed across 3 rounds · 2022–2023
▶$23.2MraisedDec 2025 · 201 investors · OtherRule 506(b)
▶$23.2MraisedDec 2025 · 201 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thierry ThaureExecutive Officer, Director
- Michel GagnerExecutive Officer, Director
- Offering amount
- $25.4M
- Amount sold
- $23.2M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$4.7MraisedNov 2023 · 31 investors · OtherRule 506(b)
▶$4.7MraisedNov 2023 · 31 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michel GagnerExecutive Officer, Director
- Thierry ThaureExecutive Officer, Director
- Offering amount
- $25.4M
- Amount sold
- $4.7M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$18.6MraisedJan 2023 · 88 investors · OtherRule 506(b)
▶$18.6MraisedJan 2023 · 88 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michel GagnerExecutive Officer, Director
- Thierry ThaureExecutive Officer, Director
- Offering amount
- $20.2M
- Amount sold
- $18.6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Gtmetabolic do?
- GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.
- Who are Gtmetabolic's investors?
- Gtmetabolic's investors include Healthtech Capital, Krillion Ventures.
- How much funding has Gtmetabolic raised?
- Gtmetabolic has disclosed $46.5M raised across 3 rounds.
- Where is Gtmetabolic headquartered?
- Gtmetabolic is headquartered in Saint Michael, US.